Jones Financial Companies
BBIO icon

Jones Financial Companies’s BridgeBio Pharma BBIO Stock Holding History

Jones Financial Companies’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
29,138
+7,887
+37% +$552K ﹤0.01% 1569
2026
Q1 		$1.48M Buy
21,251
+19,809
+1,374% +$1.44M ﹤0.01% 1558
2025
Q4 		$110K Buy
1,442
+176
+14% +$11.6K ﹤0.01% 2184
2025
Q3 		$63.4K Buy
1,266
+790
+166% +$38.5K ﹤0.01% 2279
2025
Q2 		$21.4K Sell
476
-24
-5% -$873 ﹤0.01% 2565
2025
Q1 		$17.6K Buy
+500
New +$16.9K ﹤0.01% 2486

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Jones Financial Companies's BBIO Position: Q2 2026 in Review

Jones Financial Companies increased its BridgeBio Pharma (BBIO) stake by 37% in Q2 2026, buying an estimated $552K and bringing the position to 29,138 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1569.

Jones Financial Companies first reported a position in BBIO in Q1 2025 and has held it in 6 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Jones Financial Companies held 29,138 shares of BridgeBio Pharma worth $2.05M as of Q2 2026.
  • Jones Financial Companies bought 7,887 BridgeBio Pharma shares in Q2 2026, an estimated $552K.
  • BridgeBio Pharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1569 holding.
  • Jones Financial Companies first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 6 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.